NCT07276607

Brief Summary

This parallel-group randomized controlled trial was conducted between Aprıl 2025 and December 2025 at a Training and Research Hospital in Türkiye among women who applied for Pap smear testing. A total of 128 participants aged 30-56 years were included. Data were collected at three time points using the Personal Information Form, Visual Analog Scale (VAS), and State-Trait Anxiety Inventory (STAI). A mixed-model ANOVA was applied to address the effects of time, group, and time × group interactions. Statistical significance was set at p≤0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 28, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
Last Updated

April 22, 2026

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

November 28, 2025

Last Update Submit

April 18, 2026

Conditions

Keywords

Painanxietynada yoga musicpap smearstress ball

Outcome Measures

Primary Outcomes (3)

  • Personal Information Form

    It is a form prepared by the researcher based on the relevant literature to assess the sociodemographic characteristics of the participants.

    Average 8 Years

  • Visual Analog Scale

    The Visual Analogue Scale (VAS) was first developed in 1921 by Hayes and Patterson. The standard VAS, as generally accepted, is a semi-quantitative, ordinal scale consisting of a 100-mm line. This scientifically accepted standard length aims to provide an easy and quantitative method of assessment. The VAS was first used as a self-rated tool to measure mood in 1969 by Zealley and Aitken. Studies conducted with VAS in patients experiencing pain have shown that the horizontal format is used more frequently. The VAS is typically defined as a 10-cm line, either horizontal or vertical, starting with "No Pain" and ending with "Unbearable Pain." This line may be presented as a simple straight line or divided into equal segments. When used to assess pain, it may also include descriptive pain labels placed along the line. The VAS has been a successful assessment tool in many studies for determining the effects of treatment. In our study, participants were asked to indicate their pain level o

    Average 8 Years

  • Spielberger State Anxiety Inventory

    Spielberger's State-Trait Anxiety Inventory (STAI): Developed in 1964 by Spielberger et al., the State-Trait Anxiety Inventory was designed to measure the state and trait anxiety levels of both normal and clinical populations. The scale was adapted into Turkish by Öner and Le Compte. It is a self-report instrument composed of brief statements. The State Anxiety Inventory (SAI) provides information only about how the individual feels at that specific moment, whereas the Trait Anxiety Inventory (TAI) was developed to assess anxiety experienced over the past seven days. The STAI consists of two subscales, each containing 20 items, rated on a 4-point Likert scale. In a study conducted with both healthy and clinical samples, in 2000 by Aydemir and Köroğlu reported reliability coefficients ranging from .83 to .87.

    Average 8 Years

Study Arms (4)

Group 1

EXPERIMENTAL

Nada Yoga Music

Other: Nada Yoga Music

Group 2

EXPERIMENTAL

Stress Ball

Other: Stress Ball group:

Group 3

EXPERIMENTAL

Nada Yoga Music + Stress Ball

Other: Nada Yoga Music + Stress Ball group

Group 4

NO INTERVENTION

standard care group

Interventions

Participants listened to Nada Yoga music through headphones for 15 minutes before and 15 minutes after the Pap smear procedure.

Group 1

Participants were instructed to perform squeeze-release exercises using a medium-firm stress ball during the procedure.

Group 2

Participants both listened to Nada Yoga music and performed stress ball exercises concurrently.

Group 3

Eligibility Criteria

Age30 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Details"Women undergoing a cervical cancer screening test (Pap smear)"
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between 30 and 65 years of age
  • Having no communication barriers
  • Applying for a Pap smear test
  • Volunteering to participate in the study

You may not qualify if:

  • Having any condition that prevents listening to music (e.g., hearing loss)
  • Having any physical limitation that prevents the use of a stress ball
  • Having a diagnosed psychiatric disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ağri İbrahim Çeçen Universty

Ağrı, Ağrı, 04100, Turkey (Türkiye)

Location

Related Publications (1)

  • Yanes AF, Weil A, Furlan KC, Poon E, Alam M. Effect of Stress Ball Use or Hand-holding on Anxiety During Skin Cancer Excision: A Randomized Clinical Trial. JAMA Dermatol. 2018 Sep 1;154(9):1045-1049. doi: 10.1001/jamadermatol.2018.1783.

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Nurten Özçalkap

    AĞRI İBRAHİM ÇEÇEN UNIVERSTY

    PRINCIPAL INVESTIGATOR
  • SİBEL YÜCETÜRK

    SİNOP UNIVERSTY

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This research was a prospective, parallel, randomized controlled trial with pretest, posttest, and follow-up measurements.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asistant Professor

Study Record Dates

First Submitted

November 28, 2025

First Posted

December 11, 2025

Study Start

April 1, 2025

Primary Completion

July 30, 2025

Study Completion

October 31, 2025

Last Updated

April 22, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

we don't share individual participant data with other researchers

Locations